MISTRAS Group is most often covered alongside BOHA!, which appears in 2 of these 3 stories. Across a 166-day span, the pace is roughly 0.1 stories per week. The busiest single day carried 2. earnings accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about MISTRAS Group
MISTRAS Group is most often covered alongside BOHA!, which appears in 2 of these 3 stories. Across a 166-day span, the pace is roughly 0.1 stories per week. The busiest single day carried 2. earnings accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. MISTRAS Group appears in 3 tracked Cross-Sector stories published from March 4, 2026 through August 16, 2026. The tracked stories average 3 original sources each.
Stories tracked
3
Per week
0.1
Sources per story
3
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering MISTRAS Group. Shared-story counts are live from our verified record — not editorial picks.
DeFi Technologies' Q2 earnings call appeared alongside industrial results from Mistras and TransAct, but details were limited. The cluster highlights why public crypto equities face scrutiny as investors seek fundamental revenue and treasury metrics.
Mistras Group posted a record second-quarter adjusted EBITDA of $25.8 million on 4.2% revenue growth, while TransAct Technologies raised full-year guidance after underlying sales rose 8% excluding tariff refunds.
MISTRAS, Miller Industries, and red violet reported their Q4 and FY 2025 results, highlighting a year of operational efficiency and data-driven growth. The results underscore a broader trend of margin expansion in industrial services and the continued scaling of cloud-based risk management platforms.